<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01811966</url>
  </required_header>
  <id_info>
    <org_study_id>UKGMVolume</org_study_id>
    <secondary_id>UKGMVolume</secondary_id>
    <nct_id>NCT01811966</nct_id>
  </id_info>
  <brief_title>Preoperative Volume Substitution in Elective Surgery Patients</brief_title>
  <official_title>Preoperative Volume Substitution in Fasting Patients Undergoing Elective Surgery - Impact on Hemodynamic Stability During Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Philipps University Marburg Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Philipps University Marburg Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Preoperative fasting can evoke a hypovolemia which may cause a hemodynamic instability during
      introduction of anesthesia.

      The purpose of this study is to test the hypothesis that a defined preoperative volume
      substitution compared to standard procedure will result in a reduced incidence of hemodynamic
      instabilities during introduction of anesthesia in elective surgery patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The preoperative fasting period often lasts longer than 2 hours as recommended by various
      national and international anesthetic guidelines. Thus, hypovolemia is more often then
      anticipated. In awake patients this condition is often masked. Introduction of anesthesia
      often leads to an unmasking of hypovolemia with a consecutive hemodynamic instability.

      Aim of the study is to test the hypothesis that a preoperative volume substitution (8 ml/kg
      RingerAcetate Solution in 15 min. prior to introduction of anesthesia) reduces possible
      hemodynamic instabilities during initiation of anesthesia.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">February 2015</completion_date>
  <primary_completion_date type="Actual">February 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>hemodynamic instability</measure>
    <time_frame>at time of introduction of anesthesia</time_frame>
    <description>Hemodynamic instability during induction of anesthesia (0-10 min), defined as at least one of the following:
Systolic blood pressure &lt; 80 mmHg or decrease of 20% in preexistent hypertension
Mean blood pressure &lt; 50 mmHg or decrease of 20% or &gt; 20 mmHg in preexistent hypertension
Bradycardia &lt; 45/min or decrease of 20% in preexistent bradycardia &lt; 60/min.
Tachycardia &gt; 120/min
Cardiac index &lt; 2.0 l/min/m²</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stroke volume index &gt; 35 ml/m2</measure>
    <time_frame>at time of anesthesia</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke volume variation &lt; 12 %</measure>
    <time_frame>at time of anesthesia</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Enddiastolic area (EDA) &gt; 10 cm2</measure>
    <time_frame>at time of anesthesia</time_frame>
    <description>transthoracic echocardiographic parasternal short axis enddiastolic area</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>inferior vana cava diameter (VCI) &gt; 15 mm</measure>
    <time_frame>at time of anesthesia</time_frame>
    <description>transthoracic echocardiographic inferior vena cava diameter</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">220</enrollment>
  <condition>Hemodynamic Instability</condition>
  <condition>Hypovolemia</condition>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>preoperative none substitution of i.v. fluids.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Volume</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>preoperative substitution of a defined amount of i.v. fluids (8 ml/kg RingerAcetate solution for 15 min prior to introduction of anesthesia).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Volume</intervention_name>
    <arm_group_label>Volume</arm_group_label>
    <other_name>RingerAcetate Solution</other_name>
    <other_name>cristalloide</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control</intervention_name>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥ 18 years

          -  thyreoid, parathyroid or gallbladder surgery

          -  general anesthesia

        Exclusion Criteria:

          -  coronary artery disease

          -  congestive heart disease (≥ New York Heart Association (NYHA) 2)

          -  insulin dependent diabetes mellitus

          -  renal insufficiency (creatinine &gt; 2,0 mg/dl)

          -  cerebrovascular disease

          -  severe hypertension (≥ antihypertensive drugs)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Kratz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesia and Intensive Care Medicine, University Hospital Marburg, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital of Marburg, Department of Anesthesia</name>
      <address>
        <city>Marburg</city>
        <zip>D-35033</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 13, 2013</study_first_submitted>
  <study_first_submitted_qc>March 14, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 15, 2013</study_first_posted>
  <last_update_submitted>July 28, 2015</last_update_submitted>
  <last_update_submitted_qc>July 28, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 29, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Philipps University Marburg Medical Center</investigator_affiliation>
    <investigator_full_name>Dr. Thomas Kratz</investigator_full_name>
    <investigator_title>Dr. Thomas Kratz</investigator_title>
  </responsible_party>
  <keyword>preoperative volume substitution</keyword>
  <keyword>hypovolemia</keyword>
  <keyword>preoperative fasting</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypovolemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

